To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of patients with (a) suspected and (b) confirmed rare cancers who have access to treatments through clinical trials of medications currently approved for other indications.
The Department is committed to ensuring that all patients, including those with rare cancers, have access to cutting-edge clinical trials, including trials where medicines are repurposed, as well as innovative, lifesaving treatments.The Department is work...
Rare Cancers: Clinical Trials